The Oncology Institute logo

Find a Clinical Trial

You can be part of a cutting-edge clinical trial!

The Oncology Institute of Hope and Innovation is a leader in clinical trials. Our goal: to advance the treatment of cancer. Our team currently conducts clinical trials for virtually every type of cancer, and we constantly enroll patients in new trials to ensure they have access to the latest therapeutics appropriate for their clinical condition.

  • Our research helps us:
  • Evaluate the effectiveness of treatment
  • Reduce the risk of complications
  • Lower costs and save resources
  • Continually refine our clinical approach to cancer care

Interested in participating in a clinical trial? Following is some helpful information to help you decide.

What are clinical trials?

A cancer treatment clinical trial is a study conducted with patients in order to evaluate the safety and effectiveness of a new therapy, diagnostic test, or prevention method. A clinical trial also helps determine new ways to use current therapies and drugs.

Clinical trials are conducted in four phases. The FDA requires clinical trials before any kind of medicine can be approved for the general population.

Clinical trial conductors sign up patients to participate. Without patients, there would be no clinical trials!

Doctor helping an older man
Man Writing

Who can participate in a clinical trial?

All clinical trials have guidelines about who can participate in order to ensure reliable results. The factors that allow someone to participate in a clinical trial are called “inclusion criteria” and those that disallow someone from participating are called “exclusion criteria.”

  • These criteria are based on factors such as:
  • Age
  • Gender
  • Type and stage of a disease
  • Previous treatment history
  • Other medical conditions

Before joining a clinical trial, a participant must qualify for the study.

Sometimes, completely healthy people are needed, while at other times, people with specific illnesses and conditions are required.

Is it safe to participate in a clinical trial?

Absolutely! Your safety is our priority during your participation in a clinical trial!

Your participation is completely voluntary. You may withdraw from the trial at any time if you start to feel uncomfortable.

If you qualify for one of our studies, we will discuss the details of the trial. This is called the “informed consent” process.

This helps you and your family understand the key elements of the trial including:

  • Trial design
  • Trial medication
  • Tests you will have
  • What you will be asked to do (e.g., daily documentation of diaries)
  • Possible risks and benefits of the trial medication, examinations, and procedures

This is also the time for you to ask any questions you may have.

You will be closely monitored throughout the trial by our highly trained and dedicated physicians and staff to ensure your safety. We take care of our patients as if they were our family.

What are the benefits of participating in a clinical trial?

There are many! Following are the top four benefits:

1. You will be a part of an effort for the greater good. A steady supply of patients is needed to keep clinical trials going. The more patients who participate, the greater the chance we achieve a breakthrough in medicine.

2. You will have access to medication or treatments that aren’t available to the general public. You may be among the first to benefit from the latest cutting-edge research as it moves out of the laboratory and into doctors’ hands.

3. You will play an active role in your healthcare—and in the process, learn much more about your particular healthcare condition.

4. You will receive the highest level of personal medical attention, along with trial supplies, trial lab services, and trial medicine at no cost.

What are the four phases of a clinical trial?

The testing of new treatments in clinical trials is divided into four phases:

Phase I trials help researchers determine the most appropriate dosage and to identify any side effects that may be associated with the new treatment. This phase also helps determine the best way to deliver the new treatment—for example, if a drug should be given by injection or by mouth. Phase I trials typically involve fewer than 100 participants.

Phase II trials test the treatment in patients who have the targeted medical condition in order to begin determining its effectiveness. Researchers continue to track the drug’s safety and side effects. Phase II trials involve more patients but are still very limited in size.

Phase III trials compare the new treatment to one or more standard therapies currently in use among patients. The new treatment is sometimes combined with established therapies to determine if the combination is more effective than standard therapy alone. Safety and side effects continue to be tracked as the trial expands to include hundreds or even thousands of patients.

Phase IV trials can begin once the treatment is approved for general use to continue to monitor its safety and effectiveness and to give researchers and physicians additional information about how best to employ the new treatment.

Who sponsors clinical trials?

The sponsor can be the pharmaceutical company, research institution, or health organization that funds a clinical trial. This funding source can be a commercial enterprise, a governmental agency, or a philanthropic organization.

Search Our Clinical Trials

The Oncology Institute of Hope and Innovation currently conducts numerous clinical trials on cutting-edge cancer treatments.

I want to find a clinical trial for


Skip to content